Kopran Limited (IN:KOPRAN)
:KOPRAN
KOPRAN Stock Chart & Stats
₹152.20
-₹3.64(-1.71%)
At close: 4:00 PM EST
₹152.20
-₹3.64(-1.71%)
Day’s Range― - ―
52-Week Range₹107.00 - ₹214.65
Previous CloseN/A
Volume53.95K
Average Volume (3M)13.07K
Market Cap
₹5.82B
Enterprise Value₹7.06B
Total Cash (Recent Filing)₹372.08M
Total Debt (Recent Filing)₹1.57B
Price to Earnings (P/E)19.4
Beta1.26
Next Earnings
May 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.96%
Share Statistics
EPS (TTM)1.93
Shares Outstanding48,285,606
10 Day Avg. Volume27,236
30 Day Avg. Volume13,071
Financial Highlights & Ratios
PEG Ratio-0.96
Price to Book (P/B)1.74
Price to Sales (P/S)1.44
P/FCF Ratio-67.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong CapitalizationA high equity ratio and low leverage provide durable financial flexibility, enabling the company to fund operations, absorb industry cyclicality, and access credit on better terms. This capitalization supports strategic investments and resilience through downturns over the next 2-6 months.
Improving Operational MarginsSteady revenue growth combined with a strong gross margin and a notable rise in EBIT margin indicate sustainable operational efficiency and cost control. Higher operating profitability enhances free operating cash generation potential and competitive margin resilience over the medium term.
Operating Cash GenerationOperating cash flow covering reported net income shows the core business generates cash from operations. Consistent OCF backing earnings supports working capital, debt servicing and reinvestment capacity, providing a durable cushion even if free cash flow is affected by capex.
Bears Say
Negative Free Cash FlowPersistent negative free cash flow driven by capital expenditure reduces internal funding for growth or shareholder returns. Over several months this can force external financing, constrain strategic flexibility, and increase vulnerability to funding-cost changes unless capex or conversion improves.
Declining Net ProfitabilityA falling net margin implies rising cost, pricing pressure, or non-operating headwinds eroding bottom-line conversion. If margin compression persists, it will weaken retained earnings generation and free cash flow over the medium term, limiting reinvestment and returns to shareholders.
Lower Returns On EquityA material drop in ROE signals declining capital efficiency and weaker earnings per unit of equity. Sustained lower ROE can indicate slower value creation and may require structural shifts in strategy or operations to restore historical profitability levels over the coming months.
Kopran Limited News
KOPRAN FAQ
What was Kopran Limited’s price range in the past 12 months?
Kopran Limited lowest stock price was ₹107.00 and its highest was ₹214.65 in the past 12 months.
What is Kopran Limited’s market cap?
Kopran Limited’s market cap is ₹5.82B.
When is Kopran Limited’s upcoming earnings report date?
Kopran Limited’s upcoming earnings report date is May 21, 2026 which is in 45 days.
How were Kopran Limited’s earnings last quarter?
Kopran Limited released its earnings results on Jan 22, 2026. The company reported ₹1.934 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.934.
Is Kopran Limited overvalued?
According to Wall Street analysts Kopran Limited’s price is currently Overvalued.
Does Kopran Limited pay dividends?
Kopran Limited pays a Annually dividend of ₹3 which represents an annual dividend yield of 1.96%. See more information on Kopran Limited dividends here
What is Kopran Limited’s EPS estimate?
Kopran Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kopran Limited have?
Kopran Limited has 48,285,606 shares outstanding.
What happened to Kopran Limited’s price movement after its last earnings report?
Kopran Limited reported an EPS of ₹1.934 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.111%.
Which hedge fund is a major shareholder of Kopran Limited?
Currently, no hedge funds are holding shares in IN:KOPRAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kopran Limited
Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.
Technical Analysis
Kilitch Drugs (India) Limited
―
Lincoln Pharmaceuticals Ltd
―
Sakar Healthcare Ltd
―
Wanbury Limited
―
Anuh Pharma Limited
―